News

Disclosure template for 2018 data submissions

Proposals to amend the ABPI Code of Practice 2016 and the PMCPA Constitution and Procedure were agreed by ABPI members on 4 December 2018.

The report covers details of complaints made in 2017 and considered by the PMCPA in relation to the ABPI Code of Practice for the Pharmaceutical Industry. How many were received, who made them, their outcomes and sanctions

The company has brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition Thame Laboratories was required to issue a corrective statement to recipients of the letter at issue.

The Consultation closed on 10th October 2018. Many thanks to those who contributed.

All four companies have brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition, Pierre Fabre was publicly reprimanded in one case.

Both companies have brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition, PharmaMar has been publicly reprimanded and required to issue a corrective statement.

The ABPI and NHS England have issued a joint letter setting out the ambition to increase consent rates as quickly as possible for publication of payments to individuals on Disclosure UK. The letter, ​published on 22 December 2017 and signed by ABPI CEO Mike Thompson and NHSE National Director Ian Dodge,​ is now available on the ABPI website.